Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen J Mackay
Amit M Oza

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Other new targetsHelen J Mackay, Amit M Oza
Expert Opinion on Pharmacotherapy|February 27, 2016
Current and emerging treatment options in the management of advanced ovarian cancerVictor Rodriguez-Freixinos, Helen J Mackay, Katherine Karakasis, et al.
Nature Reviews. Clinical Oncology|December 21, 2018
Advances in prediction for ovarian cancer treatment stratificationAmit M Oza
Clinical Advances in Hematology & Oncology : H&O|June 20, 2020
The role of maintenance therapy in ovarian cancerAmit M Oza
Novartis Foundation Symposium|May 7, 2002
Clinical development of P glycoprotein modulators in oncologyAmit M Oza
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
Investigational New Drugs|March 15, 2011
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortiumHelen J Mackay, Heather J Au, Elaine McWhirter, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 21, 2010
Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatmentHelen J Mackay, Jacob McGee, Diego Villa, et al.
Drugs|September 22, 2023
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future OptionsVikas Garg, Amit M Oza
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2023
Assessment of Homologous Recombination Deficiency in Ovarian CancerVikas Garg, Amit M Oza
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Other new targetsHelen J Mackay, Amit M Oza
Expert Opinion on Pharmacotherapy|February 27, 2016
Current and emerging treatment options in the management of advanced ovarian cancerVictor Rodriguez-Freixinos, Helen J Mackay, Katherine Karakasis, et al.
Nature Reviews. Clinical Oncology|December 21, 2018
Advances in prediction for ovarian cancer treatment stratificationAmit M Oza
Clinical Advances in Hematology & Oncology : H&O|June 20, 2020
The role of maintenance therapy in ovarian cancerAmit M Oza
Novartis Foundation Symposium|May 7, 2002
Clinical development of P glycoprotein modulators in oncologyAmit M Oza
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
Investigational New Drugs|March 15, 2011
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortiumHelen J Mackay, Heather J Au, Elaine McWhirter, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 21, 2010
Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatmentHelen J Mackay, Jacob McGee, Diego Villa, et al.
Drugs|September 22, 2023
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future OptionsVikas Garg, Amit M Oza
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2023
Assessment of Homologous Recombination Deficiency in Ovarian CancerVikas Garg, Amit M Oza
Pageof 30